The present invention provides compounds of formula I
and pharmaceutically acceptable salts thereof.
The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as antiproliferative agents.
[EN] PYRROLOTRIAZINE KINASE INHIBITORS<br/>[FR] PYRROLOTRIAZINE EN TANT QU'INHIBITEURS DE KINASE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2007061882A2
公开(公告)日:2007-05-31
[EN] The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as antiproliferative agents. [FR] La présente invention concerne des composés de formule I et ses sels dérivés pharmaceutiquement acceptables. Ces composés de formule I inhibent l'activité de la tyrosine kinase des récepteurs Trk tels que TrkA, TrkB, TrkC ou Flt-3, ce qui les rend utiles en tant qu'agents antiproliférants.
PYRROLOTRIAZINE KINASE INHIBITORS
申请人:Chen Ping
公开号:US20070149534A1
公开(公告)日:2007-06-28
The present invention provides compounds of formula I
and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as antiproliferative agents.